Thanks, Jim, and good afternoon. Today, the company filed its Form 10-K for the year ended December 31, 2024 with the Securities and Exchange Commission. As I always do, I recommend you read this filing in its entirety. Before I get into the details for the quarter and full-year, I would like to provide a brief update on the U.S. Kodak Retirement Income Plan or KRIP. In a Form 8-K filed with the SEC on November 25, 2024, we disclosed the Board of Directors of Eastman Kodak Company, instructed the committee with an authority to manage KRIP's assets to take appropriate actions to position KRIP for a potential termination. On January 21, 2025, Kodak's Board of Directors approved the termination of KRIP effective March 31, 2025. Following the determination and satisfaction of KRIP's liabilities, Kodak should be entitled to a reversion of any remaining KRIP assets, subject to tax obligations and the funding of a new qualified defined benefit retirement plan for active employees as a replacement for KRIP. The company expects a significant portion of any reverted assets to be used to reduce long-term debt in accordance with the terms of our debt agreements, and therefore, the annual cost of servicing net debt will decline. The remaining reversion proceeds will be utilized to further the execution of the company's long-term strategy. For further details on this topic, we direct you to the liquidity portion of the MD&A section of the Form 10-K filed with the SEC today. I will now share details on the full company results, operational EBITDA and cash flow for the fourth quarter and full-year of 2024. The company's results for 2024 were in line with our expectations and reflect the continued focus on executing against our priorities and long-term plan, including driving smart revenue and aligning with the right customers, implementing pricing rationalization and cost reductions, launching new products and investing in innovation and information technology systems to increase our operational efficiency. On slide seven, we reported revenues of $266 million for the fourth quarter of 2024, compared to $275 million in the prior year quarter, reflecting a decrease of $9 million or 3%. The rate of decline in revenue is slowing, which reflects our ongoing focus on driving smart revenue and strong profitability. We have also recognized improvements in gross profit for the fourth quarter of 2024, with an increase of $4 million or 9%, when compared to the prior year quarter. Gross profit for the current year quarter was unfavorably impacted by an inventory reserve adjustment of $4 million in the electrophotographic printing business. Our gross profit percentage was 19% in the fourth quarter of 2024, compared to 17% in the prior year quarter. This improvement is a result of the actions our team has taken to mitigate the effects of the global economy to make our operations more efficient and to realize the value of our offerings. These actions have established positive momentum as we continue to drive profitable growth going forward. Foreign exchange did not impact gross profit in the current year quarter. On a U.S. GAAP basis, we reported net income of $26 million for the fourth quarter of 2024, compared to net income of $5 million in the prior year quarter, an increase of $21 million. The 2024 and 2023 fourth quarter results include income of $3 million and expense of $2 million, respectively, related to noncash changes in workers' compensation and employee benefit reserves, an expense of $4 million and $5 million, respectively, related to asset impairments. Excluding these current and prior year quarter items, net income for 2024 was $27 million, compared to net income of $12 million in the prior-year quarter, reflecting an improvement of $15 million. Operational EBITDA for the quarter was $9 million, compared to $2 million in the prior year quarter, reflecting an increase of $7 million. Excluding the impact of noncash changes in workers' compensation and employee benefit reserves in both the current and prior year quarters, operational EBITDA increased by $2 million when compared to the prior year quarter. Foreign exchange had no impact on operational EBITDA in the current year quarter. Operational EBITDA for the fourth quarter of 2024 was favorably impacted by price increases improved operational efficiency from executing on cost controls and changes in employee benefit reserves, partially offset by an inventory reserve adjustment in our EPS business that I previously mentioned, higher aluminum costs and an increase in costs associated with certain litigation matters. Moving on to the company's fourth quarter cash performance presented on slide eight. The company had a year-end cash balance of $201 million, compared with $214 million at the end of the third quarter of 2024 for a decline of $13 million from the prior period. The decline reflects our continued CapEx investment in supporting Advanced Materials & Chemicals growth initiatives, along with building working capital in this business to allow us to supply customers as we make improvements in our manufacturing facilities. For the quarter ending December 31, 2024, cash provided by operating activities was $4 million, compared to $17 million in the prior year quarter, reflecting a decline of $13 million. Current quarter cash provided by operating activities was primarily driven by the use of cash from net earnings of $10 million and cash provided by balance sheet changes of $14 million, including a change in working capital of $15 million and a decrease in other liabilities of $7 million. Cash provided by working capital was driven by actions taken to mitigate inflation and rising costs, including cost-cutting efforts, improved inventory management and implementation of pricing actions. Cash used in investing activities was $17 million in both the current-year quarter and prior-year period, reflecting no change. This use primarily represents capital additions as the company invests in growth and increasing its manufacturing capacity in its Advanced Materials & Chemicals business. Cash used in financing activities was $2 million for both the current-year quarter and prior-year period, also reflecting no change. Restricted cash decreased by $8 million in the current-year quarter, compared to a $6 million decrease in the prior-year period, primarily driven by strategic efforts to reduce cash collateral and escrow requirements for certain company obligations and business arrangements. As presented on the bottom portion of the slide, excluding the changes in restricted cash for each period and the effects of foreign exchange, the quarter-over-quarter decrease in cash and cash equivalents for the three months ending December 31, 2024, was $11 million. On slide nine, for the full-year of 2024 the company had revenues of $1.043 billion, compared to $1.117 billion in the prior year for a decline of $74 million or 7%. Adjusting for the unfavorable impact of foreign exchange of $3 million, revenue declined by $71 million or 6% compared to the prior year. Our full-year revenue decline is impacted by revenue choices regarding our core business and portfolio of products and is in line with our expectations at this point in our long-term plan. Gross profit for 2024 declined $7 million or 3% when compared to the prior year. Foreign exchange did not impact gross profit in the current year. Gross profit for 2024 was unfavorably impacted by inventory reserve adjustments in the EPS business totaling $8 million. Gross profit percentage was 19% for the full year 2024, which is flat with the prior year. On a U.S. GAAP basis, we reported net income of $102 million for 2024 and compared to net income of $75 million in 2023, an improvement of $27 million or 36% from the prior year. 2024 and 2023 results include income of $2 million and $1 million, respectively, related to noncash changes in workers' compensation and employee benefit reserves and expense of $4 million and $5 million, respectively, related to asset impairments. The current year also includes a net gain on the sale of assets of $17 million. The 2023 results include expense of $2 million related to changes in the fair value of embedded derivative liabilities and $27 million for a loss on early extinguishment of debt resulting from a refinancing transaction, as well as $9 million for a refund from a non-U.S. governmental authority. Excluding the impact of these current and prior year items, the 2024 adjusted net income was $87 million, compared to income of $99 million in the prior year, reflecting a decline of $12 million or 12%. Operational EBITDA for 2024 was $26 million, compared to $45 million in 2023 for a decline of $19 million or 42% from the prior year. Excluding the impact of noncash changes in workers' compensation and employee benefit reserves in 2024 and 2023, operational EBITDA decreased by $20 million or 45% from the prior year. Foreign exchange did not impact operational EBITDA in the current year results. Operational EBITDA for 2024 was unfavorably impacted by lower volumes and higher aluminum costs EPS business inventory reserve adjustments of $8 million, higher costs associated with investments in information technology systems and organizational structure of $5 million and costs associated with the Drupa Trade Show and certain litigation matters totaling $10 million, partially offset by improved pricing, changes in employee benefit reserves and operational efficiencies. Moving on to the company's full-year cash performance presented on slide 10. The company ended 2024 with $201 million in cash and cash equivalents a decrease of $54 million from the December 31, 2023. The decrease in cash was primarily driven by capital expenditures to fund growth initiatives in our AM&C business, investments in technology systems and organizational structure and lower profitability from operations partially offset by improvements in working capital, primarily due to cash proceeds of $40 million from brand licensing received in January of 2024. During 2024, cash used in operating activities was $7 million. Current year cash used in operating activities was primarily driven by the use of cash from net earnings of $35 million and by cash flow from balance sheet changes of $28 million, including an improvement in working capital of $41 million and a decrease in other liabilities of $46 million. Within working capital, accounts payable decreased by $3 million, inventory increased by $7 million and accounts receivable decreased by $51 million. The decrease in accounts receivable is primarily due to cash proceeds of $40 million from brand licensing transactions received in January of 2024. Our team continues to focus on improving profitability and performance in working capital, which enhances the company's ability to generate cash. Cash from operating activities declined by $45 million from the prior year, driven by a $34 million year-over-year decrease in cash flow from net earnings and an $11 million decrease in cash flow from balance sheet changes including an improvement in working capital cash flows of $52 million, offset by a decrease in cash flows from liabilities excluding borrowings and trade payables of $67 million primarily related to the recording of deferred revenue for brand licensing arrangements in 2023. Cash used in investing activities was $39 million in the current year, an increase of $7 million when compared to the prior year, primarily due to an increase in capital additions of $24 million, partially offset by proceeds from the sale of assets of $17 million. Cash used in financing activities was $23 million in the current year, compared to cash provided by financing activities of $85 million in the prior year. This change was primarily driven by net proceeds of $90 million received from refinancing transactions in the prior year and $17 million related to the prepayment of the amended and restated term loan agreement made in 2024 from the proceeds received from the sale of assets within investing activities. Restricted cash at the end of the year was $100 million, a decrease of $22 million from December 31, 2023, primarily driven by strategic efforts to reduce cash collateral and escrow requirements for certain company obligations and business arrangements. As a reminder, restricted cash primarily represents cash collateral supporting the company's undiscounted actuarial workers' compensation obligations with the New York State Workers' Compensation Board and cash collateral required under letter of credit facility in addition to escrows to secure various ongoing obligations. We continue to focus on opportunities to reduce restrictions on cash. As presented on the bottom portion of the slide, excluding the changes in restricted cash for each period, the impact of net proceeds from our refinancing transaction and the receipt of a refund from a non-U.S. governmental authority in the prior year along with the current year effect of exchange rates on cash, year-over-year decrease in cash and cash equivalents was $45 million. As stated earlier in my remarks, the company's financial results are within our expectations at this point in our long-term strategy. We will continue to focus on maintaining the strength of the foundation we have worked hard to create, which provides us the opportunity to fund our ongoing operations, invest in our growth initiatives and convert our historical investments into returns for the long-term. Finally, as disclosed in our Form 10-K, we remain in compliance with all applicable financial covenants. I will now turn the discussion back to Jim. Thank you.